688 related articles for article (PubMed ID: 26038289)
1. Latent tuberculosis infection--Revisiting and revising concepts.
Salgame P; Geadas C; Collins L; Jones-López E; Ellner JJ
Tuberculosis (Edinb); 2015 Jul; 95(4):373-84. PubMed ID: 26038289
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
3. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
[TBL] [Abstract][Full Text] [Related]
4. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.
Erkens CG; Dinmohamed AG; Kamphorst M; Toumanian S; van Nispen-Dobrescu R; Alink M; Oudshoorn N; Mensen M; van den Hof S; Borgdorff M; Verver S
Int J Tuberc Lung Dis; 2014 Apr; 18(4):413-20. PubMed ID: 24670695
[TBL] [Abstract][Full Text] [Related]
5. Close contact interferon-gamma response to the new PstS1
de Araujo LS; de Bárbara Moreira da Silva Lins N; Leung JA; Mello FC; Saad MH
BMC Res Notes; 2017 Jan; 10(1):59. PubMed ID: 28114976
[TBL] [Abstract][Full Text] [Related]
6. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
Campbell JR; Krot J; Elwood K; Cook V; Marra F
Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
[TBL] [Abstract][Full Text] [Related]
7. Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays.
Pai M; Behr M
Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763261
[TBL] [Abstract][Full Text] [Related]
8. Interferon gamma release assays: principles and practice.
Lalvani A; Pareek M
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
[TBL] [Abstract][Full Text] [Related]
9. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
[TBL] [Abstract][Full Text] [Related]
10. Position statement on interferon-γ release assays for the detection of latent tuberculosis infection.
Bastian I; Coulter C;
Commun Dis Intell Q Rep; 2017 Dec; 41(4):E322-E336. PubMed ID: 29864386
[TBL] [Abstract][Full Text] [Related]
11. Does an interferon-gamma release assay change practice in possible latent tuberculosis?
Tiernan JF; Gilhooley S; Jones ME; Chalmers JD; McSparron C; Laurenson IF; Hill AT
QJM; 2013 Feb; 106(2):139-46. PubMed ID: 23159840
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.
Starke JR;
Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024
[TBL] [Abstract][Full Text] [Related]
13. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
[TBL] [Abstract][Full Text] [Related]
15. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
[TBL] [Abstract][Full Text] [Related]
16. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
[TBL] [Abstract][Full Text] [Related]
17. Immunological characterization of latent tuberculosis infection in a low endemic country.
de Paus RA; van Meijgaarden KE; Prins C; Kamphorst MH; Arend SM; Ottenhoff THM; Joosten SA
Tuberculosis (Edinb); 2017 Sep; 106():62-72. PubMed ID: 28802407
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis for Latent Tuberculosis Infection: New Alternatives.
Carranza C; Pedraza-Sanchez S; de Oyarzabal-Mendez E; Torres M
Front Immunol; 2020; 11():2006. PubMed ID: 33013856
[TBL] [Abstract][Full Text] [Related]
19. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
[TBL] [Abstract][Full Text] [Related]
20. Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road?
Mwaba P; Chakaya JM; Petersen E; Wejse C; Zumla A; Kapata N
Int J Infect Dis; 2020 Mar; 92S():S69-S71. PubMed ID: 32119979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
